The DxC 500 AU Chemistry Analyzer from Beckman Coulter expands its portfolio with proven Six Sigma performance.

Leader in clinical diagnostics Beckman Coulter Diagnostics will introduce the DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, February 5-8, 2024. This is one of several new solutions from Beckman Coulter that are intended to meet all the requirements of healthcare systems that want to enhance the capabilities and technology of independent and satellite hospital laboratories to supplement central hub laboratories.

“Hub-and-spoke clinical laboratory models optimize resources to improve access to testing services and enhance overall standardization for quality testing and positive impact on inventory and cost management across a health system,” stated Kathleen Orland, Senior Vice President, Business Unit, General Manager, Chemistry and Immunoassay, Beckman Coulter Diagnostics. “Across the globe, healthcare systems are strategically adopting hub-and-spoke models for better efficiency and healthcare access.” The new DxC 500 AU Chemistry Analyzer expands the capabilities of spoked labs with a broad menu of high-quality assays that deliver consistent, commutable results across Beckman Coulter’s AU clinical chemistry systems, positively impacting clinical decision-making and patient outcomes.